228 related articles for article (PubMed ID: 29284740)
1. Familial and Somatic
Peng H; Prokop J; Karar J; Park K; Cao L; Harbour JW; Bowcock AM; Malkowicz SB; Cheung M; Testa JR; Rauscher FJ
Cancer Res; 2018 Mar; 78(5):1200-1213. PubMed ID: 29284740
[TBL] [Abstract][Full Text] [Related]
2. Kinetic Characterization of ASXL1/2-Mediated Allosteric Regulation of the BAP1 Deubiquitinase.
Peng H; Cassel J; McCracken DS; Prokop JW; Sementino E; Cheung M; Collop PR; Polo A; Joshi S; Mandell JP; Ayyanathan K; Hinds D; Malkowicz SB; Harbour JW; Bowcock AM; Salvino J; Kennedy EJ; Testa JR; Rauscher FJ
Mol Cancer Res; 2021 Jul; 19(7):1099-1112. PubMed ID: 33731362
[TBL] [Abstract][Full Text] [Related]
3. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
[TBL] [Abstract][Full Text] [Related]
4. BAP1/ASXL1 recruitment and activation for H2A deubiquitination.
Sahtoe DD; van Dijk WJ; Ekkebus R; Ovaa H; Sixma TK
Nat Commun; 2016 Jan; 7():10292. PubMed ID: 26739236
[TBL] [Abstract][Full Text] [Related]
5. Impacts of Cancer-associated Mutations on the Structure-Activity Relationship of BAP1.
Puri S; Chen SN; Chiu YH; Draczkowski P; Ko KT; Yang TJ; Wang YS; Uchiyama S; Hsu SD
J Mol Biol; 2022 May; 434(9):167553. PubMed ID: 35317997
[TBL] [Abstract][Full Text] [Related]
6. Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1/K2 transcription network.
Xia YK; Zeng YR; Zhang ML; Liu P; Liu F; Zhang H; He CX; Sun YP; Zhang JY; Zhang C; Song L; Ding C; Tang YJ; Yang Z; Yang C; Wang P; Guan KL; Xiong Y; Ye D
Protein Cell; 2021 Jul; 12(7):557-577. PubMed ID: 32683582
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin recognition of BAP1: understanding its enzymatic function.
Hanpude P; Bhattacharya S; Kumar Singh A; Kanti Maiti T
Biosci Rep; 2017 Oct; 37(5):. PubMed ID: 28935764
[TBL] [Abstract][Full Text] [Related]
8. Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.
Lee SW; Youn H; Kim EJ; Um SJ
Mol Cell; 2013 Jul; 51(2):200-10. PubMed ID: 23850490
[TBL] [Abstract][Full Text] [Related]
9. Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.
Daou S; Barbour H; Ahmed O; Masclef L; Baril C; Sen Nkwe N; Tchelougou D; Uriarte M; Bonneil E; Ceccarelli D; Mashtalir N; Tanji M; Masson JY; Thibault P; Sicheri F; Yang H; Carbone M; Therrien M; Affar EB
Nat Commun; 2018 Oct; 9(1):4385. PubMed ID: 30349006
[TBL] [Abstract][Full Text] [Related]
10. Cancer associated missense mutations in BAP1 catalytic domain induce amyloidogenic aggregation: A new insight in enzymatic inactivation.
Bhattacharya S; Hanpude P; Maiti TK
Sci Rep; 2015 Dec; 5():18462. PubMed ID: 26680512
[TBL] [Abstract][Full Text] [Related]
11. BAP1 Missense Mutations in Cancer: Friend or Foe?
Okonska A; Felley-Bosco E
Trends Cancer; 2019 Nov; 5(11):659-662. PubMed ID: 31735283
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis for the Activation of the Deubiquitinase Calypso by the Polycomb Protein ASX.
De I; Chittock EC; Grötsch H; Miller TCR; McCarthy AA; Müller CW
Structure; 2019 Mar; 27(3):528-536.e4. PubMed ID: 30639226
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.
Balasubramani A; Larjo A; Bassein JA; Chang X; Hastie RB; Togher SM; Lähdesmäki H; Rao A
Nat Commun; 2015 Jun; 6():7307. PubMed ID: 26095772
[TBL] [Abstract][Full Text] [Related]
14. Loss of the tumor suppressor BAP1 causes myeloid transformation.
Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM
Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500
[TBL] [Abstract][Full Text] [Related]
15. Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis.
Asada S; Goyama S; Inoue D; Shikata S; Takeda R; Fukushima T; Yonezawa T; Fujino T; Hayashi Y; Kawabata KC; Fukuyama T; Tanaka Y; Yokoyama A; Yamazaki S; Kozuka-Hata H; Oyama M; Kojima S; Kawazu M; Mano H; Kitamura T
Nat Commun; 2018 Jul; 9(1):2733. PubMed ID: 30013160
[TBL] [Abstract][Full Text] [Related]
16. Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1.
Thomas JF; Valencia-Sánchez MI; Tamburri S; Gloor SL; Rustichelli S; Godínez-López V; De Ioannes P; Lee R; Abini-Agbomson S; Gretarsson K; Burg JM; Hickman AR; Sun L; Gopinath S; Taylor HF; Sun ZW; Ezell RJ; Vaidya A; Meiners MJ; Cheek MA; Rice WJ; Svetlov V; Nudler E; Lu C; Keogh MC; Pasini D; Armache KJ
Sci Adv; 2023 Aug; 9(32):eadg9832. PubMed ID: 37556531
[TBL] [Abstract][Full Text] [Related]
17. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O.
Mashtalir N; Daou S; Barbour H; Sen NN; Gagnon J; Hammond-Martel I; Dar HH; Therrien M; Affar el B
Mol Cell; 2014 May; 54(3):392-406. PubMed ID: 24703950
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of catalytic cysteine of human deubiquitinase BAP1 triggers misfolding and aggregation in addition to functional loss.
Puri S; Hsu SD
Biochem Biophys Res Commun; 2022 Apr; 599():57-62. PubMed ID: 35176625
[TBL] [Abstract][Full Text] [Related]
19. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
Okino Y; Machida Y; Frankland-Searby S; Machida YJ
J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
[TBL] [Abstract][Full Text] [Related]
20. Reducing hyperactivated BAP1 attenuates mutant ASXL1-driven myeloid malignancies in human haematopoietic cells.
Bai J; Chen Z; Chen C; Zhang M; Zhang Y; Song J; Yuan J; Jiang X; Xing W; Yang J; Bai J; Zhou Y
Cancer Lett; 2021 Oct; 519():78-90. PubMed ID: 34186160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]